U.S. Physical Therapy (USPH) Stock Forecast & Price Target $91.74 +0.41 (+0.44%) As of 10:49 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock U.S. Physical Therapy - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 8 Analyst RatingsSell0Hold3Buy5 Based on 8 Wall Street analysts who have issued ratings for U.S. Physical Therapy in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 3 have given a hold rating, 4 have given a buy rating, and 1 has given a strong buy rating for USPH. Consensus Price Target $110.2520.17% Upside According to the 8 analysts' twelve-month price targets for U.S. Physical Therapy, the average price target is $110.25. The highest price target for USPH is $115.00, while the lowest price target for USPH is $103.00. The average price target represents a forecasted upside of 20.17% from the current price of $91.75. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for USPH and Related Stocks Enter your email address to receive the latest news and analysts' ratings for U.S. Physical Therapy and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. USPH Analyst Ratings Over TimeTypeCurrent Forecast10/24/24 to 10/24/251 Month Ago9/24/24 to 9/24/253 Months Ago7/26/24 to 7/26/251 Year Ago10/25/23 to 10/24/24Strong Buy1 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s)0 Strong Buy rating(s)Buy4 Buy rating(s)4 Buy rating(s)4 Buy rating(s)2 Buy rating(s)Hold3 Hold rating(s)2 Hold rating(s)1 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$110.25$110.25$109.00$105.00Forecasted Upside20.17% Upside34.51% Upside46.64% Upside28.19% UpsideConsensus RatingModerate BuyModerate BuyBuyModerate Buy USPH Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History USPH Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table U.S. Physical Therapy Stock vs. The CompetitionTypeU.S. Physical TherapyMedical CompaniesS&P 500Consensus Rating Score 2.75 2.33 2.52Consensus RatingModerate BuyHoldModerate BuyPredicted Upside20.97% Upside1,311.17% Upside12.13% UpsideNews Sentiment RatingNeutral NewsSee Recent USPH NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/24/2025Barrington Research3 of 5 starsMichael Petusky2 of 5 starsReiterated RatingOutperform$103.00+13.01%10/8/2025Weiss Ratings0 of 5 stars Reiterated RatingHold (C)9/18/2025JPMorgan Chase & Co.2 of 5 starsBenjamin Rossi Not RatedInitiated CoverageOverweight$110.00+39.63%8/8/2025Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeHold4/22/2025JMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingConstantine DavidesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingMarket Outperform$113.00 ➝ $113.00+69.72%2/27/2025William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingMarket Perform12/16/2024Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingC. DavidesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeStrong-Buy12/16/2024Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeNeutral ➝ Buy$100.00 ➝ $115.00+23.05%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 10:50 AM ET. USPH Forecast - Frequently Asked Questions What is U.S. Physical Therapy's forecast for 2025? According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for U.S. Physical Therapy is $110.25, with a high forecast of $115.00 and a low forecast of $103.00. Should I buy or sell U.S. Physical Therapy stock right now? 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 3 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" USPH shares. Does U.S. Physical Therapy's stock price have much upside? According to analysts, U.S. Physical Therapy's stock has a predicted upside of 20.17% based on their 12-month stock forecasts. Has U.S. Physical Therapy been upgraded by Wall Street analysts recently? Over the previous 90 days, U.S. Physical Therapy's stock had 1 upgrade by analysts. What analysts cover U.S. Physical Therapy? U.S. Physical Therapy has been rated by research analysts at Barrington Research, JPMorgan Chase & Co., Weiss Ratings, and Zacks Research in the past 90 days. Do Wall Street analysts like U.S. Physical Therapy more than its competitors? Analysts like U.S. Physical Therapy more than other "medical" companies. The consensus rating for U.S. Physical Therapy is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how USPH compares to other companies. Stock Forecasts and Research Tools Related Companies Acadia Healthcare Stock Forecast Brookdale Senior Living Stock Forecast Select Medical Stock Forecast Petco Health and Wellness Stock Forecast Community Health Systems Stock Forecast HCA Healthcare Stock Forecast Alcon Stock Forecast Tenet Healthcare Stock Forecast Universal Health Services Stock Forecast Encompass Health Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:USPH) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthFed vs. Trump - A War With American Wealth At Stake The Fed's defiance of Trump thickens the plot to contro...American Hartford Gold | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding U.S. Physical Therapy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share U.S. Physical Therapy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free USPH Stock Alerts